Home » Topics » Regulatory

Regulatory
RSS

Xofluza approved in Japan for treatment of influenza types A and B

Feb. 23, 2018

FDA approves Imfinzi for unresectable stage III NSCLC

Feb. 19, 2018

Gilead Sciences' Harvoni approved for new indication in Japan

Feb. 19, 2018

FDA approves Erleada for non-metastatic castration-resistant prostate cancer

Feb. 15, 2018

FDA approves Symdeko to treat underlying cause of cystic fibrosis

Feb. 13, 2018

FDA approves Biktarvy to treat HIV-1 infection

Feb. 8, 2018

FDA approves Synergy Pharmaceuticals' Trulance for IBS-C

Jan. 26, 2018

EC extends approval of Adcetris to include cutaneous T-cell lymphoma

Jan. 23, 2018

Nailin approved in Japan for onychomycosis

Jan. 23, 2018

Etanercept biosimilar approved in Japan

Jan. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...